LOGOLOGOLOGOLOGO
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

EuropaBio position on the proposal for a Regulation on compulsory licensing for crisis management

28/07/2023

PRESS RELEASE

Brussels, 28 July 2023

Today EuropaBio published its position on the proposal for a Regulation on compulsory licensing for crisis management as part of its ongoing work to protect biotech innovation in Europe.

The far-reaching proposal presented by the European Commission risks further eroding intellectual property protection and set a dangerous precedent about the stability and value of intellectual property rights (IPRs) in Europe. The experience of the COVID-19 pandemic has shown that IP is not a barrier to access as vaccines and therapeutics were delivered in sufficient quantities to and from Europe without the use of compulsory licensing. The proposed Regulation will also significantly impact innovation from small and growing companies for whom patents are often the key value to their existence and ability to raise investments to continue their development.

EuropaBio Director-General Dr. Claire Skentelbery said: “The proposal undermines intellectual property and consequently life sciences and biotechnology innovation. Biotechnology-derived innovations have been critical in the pandemic response, and none of these would have been possible without a robust IP framework to secure investment in high-risk research, infrastructures, skills and diversified products. Undermining IP in the EU will only increase our dependency on other regions as innovators commit into countries that recognise IP as a as the main driver for innovation.”

It is essential that compulsory licensing remains a last resort option, triggered appropriately within the right legal framework, and subject to a continuous, independent, and fair judicial oversight through all phases of the compulsory licensing. process EuropaBio is committed to engage with policymakers and stakeholders to ensure the proposal does not negatively impact Europe’s innovative biotech industries.

The full paper can be downloaded below.

EuropaBio position on the proposal for a Regulation on compulsory licensing for crisis management


Download
EuropaBio's Feedback to the European Commission
Share
Francesca Degli Agostini
Francesca Degli Agostini

Related posts

14/09/2023

Revision of the Detergents Regulation: EuropaBio policy asks for Microbial-based Cleaning Products


Read more
14/09/2023

European Commission proposal on New Genomic Techniques – a first step towards modernizing the EU GMO framework


Read more
13/09/2023

EU Industrial Forum report: Advanced Manufacturing at the heart of a resilient, sustainable and competitive Europe


Read more

Important links

  • Genopole joins EuropaBio: French biotechnology on a global scale
  • Revision of the Detergents Regulation: EuropaBio policy asks for Microbial-based Cleaning Products

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
LOGO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies